Intelligence briefing
Longevity signals.
What serious people are reading about the longevity economy — landmark science, the capital moving in, founder voices, and policy — curated alongside our own evidence layer. Every item links to its source.
The Longevity Operating System
Why, in the AI era, the scarcest asset to manage is no longer your time — but your healthspan. The five-layer system every person can run, and the evidence layer it's missing.
Read the whitepaperThe Hallmarks of Aging: An Expanding Universe
The field's foundational map — twelve hallmarks now define what aging is and where intervention is possible.
Altos Labs launched with ~$3B for cellular rejuvenation
Backed by Bezos and Yuri Milner with Nobel laureate Shinya Yamanaka — the largest private bet that aging is programmable.
Hevolution commits up to $1B/year to healthspan science
Saudi-established and now among the world's largest geroscience funders — sovereign capital is entering longevity.
“You will, however, eventually get access to their longevity therapies.”
The Don't Die founder frames longevity as the next status frontier — and one that eventually democratizes.
Inside Putin's $26 Billion Quest for Longevity
From organ printing to genetics — antiaging research is now treated as a state-level priority.
“Outlive” turned longevity medicine into a mainstream bestseller
Healthspan, not just lifespan — the consumer demand thesis behind the entire category.
9 evidence-graded longevity ingredients, 1,415+ trials indexed
Our proprietary evidence layer — East and West — links every ingredient to clinical trials and primary literature.
First human NMN RCT: dose-dependent rise in blood NAD+
A randomized, placebo-controlled trial in middle-aged adults — the kind of primary evidence we index per ingredient.
Curated external signals are summarized and attributed to their original publishers; follow each link for the full source. Items tagged “Atlas” reference our own evidence layer. Informational only — not investment or medical advice.